OneMedForum New York 2012 Kick Off Reception Welcomed Over 50 Invited Guests
OneMedPlace kicked off OneMedForum NY 2012 with an exclusive investor networking reception to raise awareness about the upcoming 3rd annual finance conference.
feature2
OneMedRadio: NanoViricides CEO Discusses U.S. Patent
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for antiviral therapy.
Synthetic Biologics CEO Jeff Riley Discusses ‘Gene Medicine 2.0’
Synthetic Biologics (SYN) is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses.
Iconic Data Present Another Advancement in Healthcare Technology
The company’s lead product, SwiftPayMD is a recently launched mobile app for iPad and iPhone that helps doctors work more efficiently when seeing patients at the hospital.
Opexa CEO, Neil Warma Discusses a Potential Blockbuster Treatment in Numerous Autoimmune Diseases
OneMedResearch recently initiated coverage on Opexa Therapeutics, a biotechnology company developing patient-specific cellular therapies for the treatment of autoimmune diseases.
Healthcare’s Digital Revolution: Part II
Part II discusses The Waiting Room and the introduction of health tablets as a replacement to magazines making a patient visit more informative and efficient.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Alzheimer’s Drug Market Is Forecast to Experience Double-Digit Growth
Valued at almost $6bn in the seven major markets in 2011 (US, Japan, France, Germany, Italy, Spain, and the UK), the Alzheimer’s disease drug market is forecast to experience double-digit growth to 2020.
The Technology Corner: Disruptive Technology for Prostate Cancer
In this special series we present emerging technologies which hold the promise to significantly improve the prognosis of patients diagnosed with prostate cancer, and cancer in general.
The Value of Concurrent Design and DFM for Medical Devices
The final interview in our MPR series is with Leon Marucchi, Director of Industrial Design and Katie McHugh, a design engineer at the international consulting firm.